Low-risk diet for colorectal cancer in Italy

被引:8
|
作者
Calza, S
Ferraroni, M
LaVecchia, C
Franceschi, S
Decarli, A
机构
[1] Univ Milan, Ist Stat Med & Biometria, I-20133 Milan, Italy
[2] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20122 Milan, Italy
[3] Ist Ric Farmacol Mario Negri, Milan, Italy
[4] Int Agcy Res Canc, F-69372 Lyon, France
[5] Univ Brescia, Dipartimento Sci Biomed & Biotecnol, Sez Stat Med & Biometria, I-25121 Brescia, Italy
关键词
colorectal neoplasms; diet; macronutrient; risk score;
D O I
10.1097/00008469-200112000-00006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
An innovative approach was used to define a low-risk diet for colorectal cancer from a multicentric case-control study of 1953 incident cases and 4154 hospital controls from Italy. A logistic regression model was fitted on the reported intake of five macronutrients, and the estimated coefficients were used to compute a diet-related logistic risk score (LRS). The mean of LRS within risk decile ranged from 0.89 to 1.86. Total energy intake and absolute consumption of each macronutrient increased with increasing LRS. In relative terms, however, starch intake showed an almost threefold increase across subsequent score levels, while a decline was observed for unsaturated fat, sugar and protein. Saturated fat consumption remained fairly stable in relative terms. When food groups were considered, bread and cereals dishes, cakes and desserts and refined sugar were positively associated, while the consumption of vegetables, fruit, fish, poultry and olive oils was inversely associated with LRS. (C) 2001 Lippincott Williams Wilkins.
引用
收藏
页码:515 / 521
页数:7
相关论文
共 50 条
  • [1] Low-risk diet for breast cancer in Italy
    Franceschi, S
    La Vecchia, C
    Russo, A
    Negri, E
    Favero, A
    Decarli, A
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1997, 6 (11) : 875 - 879
  • [2] Diet and nasopharyngeal cancer in a low-risk population
    Farrow, DC
    Vaughan, TL
    Berwick, M
    Lynch, CF
    Swanson, GM
    Lyon, JL
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1998, 78 (06) : 675 - 679
  • [3] Diet diversity and the risk of colorectal cancer in northern Italy
    Fernandez, E
    DAvanzo, B
    Negri, E
    Franceschi, S
    LaVecchia, C
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1996, 5 (06) : 433 - 436
  • [4] Diet and risk of esophageal cancer by histologic type in a low-risk population
    Tzonou, A
    Lipworth, L
    Garidou, A
    Signorello, LB
    Lagiou, P
    Hsieh, CC
    Trichopoulos, D
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1996, 68 (03) : 300 - 304
  • [5] COLONIC INTRALUMINAL PH IN A LOW-RISK POPULATION FOR COLORECTAL-CANCER
    NAAEDER, SB
    EVANS, DF
    PYE, G
    BAKER, N
    HARDCASTLE, JD
    ARCHAMPONG, EQ
    [J]. GASTROENTEROLOGY, 1993, 104 (04) : A433 - A433
  • [6] Low-risk prostate cancer
    Stief, C. G.
    Roosen, A.
    [J]. UROLOGE, 2014, 53 (07): : 1030 - 1030
  • [7] Adjuvant chemotherapy provides a slight survival advantage in low-risk colorectal cancer
    [J]. Nature Clinical Practice Oncology, 2008, 5 (3): : 125 - 125
  • [8] The use of an optimized colonoscopy protocol in a low-risk population for colorectal cancer prevention
    Eluri, Swathi
    Crockett, Seth D.
    Baron, John A.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (05) : 1245 - 1246
  • [9] DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer
    Li, Yuan
    Liao, Leen
    Kong, Lingheng
    Jiang, Wu
    Tang, Jinghua
    Han, Kai
    Hou, Zhenlin
    Zhang, Chenzhi
    Zhou, Chi
    Zhang, Linjie
    Sui, Qiaoqi
    Xiao, Binyi
    Mei, Weijian
    Xu, Yanbo
    Yu, Jiehai
    Hong, Zhigang
    Pan, Zhizhong
    Ding, Peirong
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (01): : 218 - 225
  • [10] DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer
    Yuan Li
    Leen Liao
    Lingheng Kong
    Wu Jiang
    Jinghua Tang
    Kai Han
    Zhenlin Hou
    Chenzhi Zhang
    Chi Zhou
    Linjie Zhang
    Qiaoqi Sui
    Binyi Xiao
    Weijian Mei
    Yanbo Xu
    Jiehai Yu
    Zhigang Hong
    Zhizhong Pan
    Peirong Ding
    [J]. Clinical and Translational Oncology, 2023, 25 : 218 - 225